Internal Medicine, Medical Oncology · Newark, DE
NPI
1942618962
Since 2014
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4701 Ogletown Stanton Road, Suite 3400
Newark, DE, 19713
Phone (302) 366-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
66,139 services
Medicare patients, 2024
501
Average age 75
Drug cost, 2024
$1.6M
1,451 prescriptions
Company payments, 2025
$101
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lydia I Clements was code J9271 (injection, pembrolizumab, 1 mg), 8,000 times for 15 patients. In total Lydia I Clements billed 66,139 services in 103 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,000 | 15 | $44.40 | $355K |
| J0897 Injection, denosumab, 1 mg | Office | 4,260 | 17 | $20.33 | $87K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 2,244 | 12 | $22.07 | $50K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,500 | 13 | $15.46 | $23K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,114 | 37 | $0.09 | $101 |
| 99213 Office E&M - Established | Office | 321 | 247 | $62.74 | $20K |
| 96375 Injection Administration | Office | 208 | 45 | $12.88 | $2,678 |
| 99214 Office E&M - Established | Office | 176 | 126 | $101.78 | $18K |
| 96413 Chemotherapy Administration | Office | 170 | 63 | $106.60 | $18K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 170 | 12 | $0.80 | $135 |
| 96372 Injection Administration | Office | 99 | 43 | $11.49 | $1,137 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 81 | 24 | $0.63 | $50.88 |
| 96367 Intravenous Infusion, Hydration | Office | 75 | 26 | $23.45 | $1,758 |
| 99215 Office E&M - Established | Office | 74 | 55 | $143.71 | $11K |
| 96417 Chemotherapy Administration | Office | 72 | 18 | $53.30 | $3,838 |
By year: 2022 $1.1M for 66,699 services; 2023 $2.3M for 112,167 services; 2024 $1.5M for 66,139 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lydia I Clements prescribed most often to Medicare patients was Anastrozole, with 655 prescriptions and refills. In total Lydia I Clements wrote 1,451 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 655 | 1,893 | 196 | $27K |
| Tamoxifen Citrate Generic | 102 | 260 | 27 | $4,734 |
| Letrozole Generic | 46 | 118 | 16 | $1,059 |
| Ibrance Palbociclib | 43 | 43 | Under 11 | $720K |
| Gabapentin Generic | 41 | 49 | Under 11 | $506 |
| Olanzapine Generic | 25 | 31 | Under 11 | $287 |
| Xarelto Rivaroxaban | 23 | 44 | Under 11 | $24K |
| Acyclovir Generic | 23 | 33 | Under 11 | $691 |
| Eliquis Apixaban | 22 | 54 | Under 11 | $31K |
| Exemestane Generic | 21 | 59 | Under 11 | $2,617 |
| Oxycodone Hcl Generic | 21 | 21 | Under 11 | $248 |
| Alendronate Sodium Generic | 19 | 51 | Under 11 | $69.89 |
| Verzenio Abemaciclib | 16 | 16 | Under 11 | $255K |
| Prednisone Generic | 16 | 30 | Under 11 | $65.69 |
| Prochlorperazine Maleate Generic | 15 | 15 | Under 11 | $179 |
Brand drugs: 160 claims; generic drugs: 1,291 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lydia I Clements $101 ($101 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novartis Pharmaceuticals Corporation with $50.17.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.